The Indian Academy of Pediatrics Committee on Immunization (IAPCOI) prescribes offering the HPV vaccine to all females who can bear the cost of the vaccine. Vaccination can be given to females as young as 9 years just as in those matured of 13–26 years who have not recently finished vaccination. The essential impediment to HPV vaccination is its cost.
There are bivalent, Quadrivalent, and Nonavalent HPV vaccine for girls accessible dependent on protection against a number of HPV subtypes. HPV vaccination and normal cervical screening is the best method to forestall cervical cancer.
Human Papillomavirus (HPV)
Protect your child from developing certain types of cancers later in life by giving HPV vaccine at ages 9 to 14 years.
Between 9 to 14 Years of age
6–12 months after the first dose
Children who start the HPV vaccine series on or after their 15th birthday need three doses given over 6 months.
HPV vaccination is also recommended for everyone through age 26 years, if they were not adequately vaccinated already.
HPV vaccination is not recommended for everyone older than age 26 years. However, some adults age 27 through 45 years who were not already vaccinated may decide to get HPV vaccine after speaking with their doctor about their risk for new HPV infections and the possible benefits of vaccination. HPV vaccination in this age range provides less benefit, as more people have already been exposed to HPV.
Due to a lack of awareness and lower immunization penetration, there are very few studies conducted in India.
HPV infections and cervical precancers (abnormal cells on the cervix that can lead to cancer) have dropped significantly since the vaccine has been in use in the United States.
- Among teen girls, infections with HPV types that cause most HPV cancers and genital warts have dropped 86 percent.
- Among young adult women, infections with HPV types that cause most HPV cancers and genital warts have dropped 71 percent.
- Among vaccinated women, the percentage of cervical precancers caused by the HPV types most often linked to cervical cancer has dropped by 40 percent.
Content source: National Center for Immunization and Respiratory Diseases